Robert E. Parson

1.8k total citations · 1 hit paper
8 papers, 1.3k citations indexed

About

Robert E. Parson is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Robert E. Parson has authored 8 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in Robert E. Parson's work include Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (5 papers) and Urologic and reproductive health conditions (3 papers). Robert E. Parson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (5 papers) and Urologic and reproductive health conditions (3 papers). Robert E. Parson collaborates with scholars based in United States. Robert E. Parson's co-authors include Paula C. Southwick, Michael K. Brawer, Kevin M. Slawin, Gail H. Gasior, Patrick C. Walsh, Kathleen G Loveland, Robert C. Flanigan, Peter T. Scardino, Alan W. Partin and Anup Patel and has published in prestigious journals such as JAMA, Journal of Neurochemistry and The Journal of Urology.

In The Last Decade

Robert E. Parson

8 papers receiving 1.3k citations

Hit Papers

Use of the Percentage of Free Prostate-Specific Antigen t... 1998 2026 2007 2016 1998 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease
    1998 860 citations William J. Catalona, Alan W. Partin et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Parson United States 7 947 301 261 188 183 8 1.3k
Jacques Planas Spain 22 1.2k 1.3× 330 1.1× 222 0.9× 330 1.8× 165 0.9× 137 1.6k
T A Stamey United States 7 1.4k 1.4× 337 1.1× 491 1.9× 194 1.0× 226 1.2× 9 2.0k
Takashi Imamoto Japan 24 911 1.0× 361 1.2× 102 0.4× 255 1.4× 343 1.9× 64 1.5k
Naoto Kamiya Japan 22 796 0.8× 359 1.2× 85 0.3× 283 1.5× 338 1.8× 87 1.4k
Jo Ann V. Antenor United States 20 1.6k 1.7× 211 0.7× 488 1.9× 220 1.2× 374 2.0× 35 2.0k
J.S.P. Yuen Singapore 15 320 0.3× 481 1.6× 66 0.3× 199 1.1× 178 1.0× 38 1.1k
Daniel Keizman Israel 23 1.0k 1.1× 320 1.1× 43 0.2× 678 3.6× 291 1.6× 98 1.7k
Rosina T. Lis United States 24 973 1.0× 970 3.2× 53 0.2× 365 1.9× 246 1.3× 51 2.0k
Loredana Ciuclan United Kingdom 14 559 0.6× 509 1.7× 38 0.1× 171 0.9× 191 1.0× 23 1.3k

Countries citing papers authored by Robert E. Parson

Since Specialization
Citations

This map shows the geographic impact of Robert E. Parson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Parson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Parson more than expected).

Fields of papers citing papers by Robert E. Parson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Parson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Parson. The network helps show where Robert E. Parson may publish in the future.

Co-authorship network of co-authors of Robert E. Parson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Parson. A scholar is included among the top collaborators of Robert E. Parson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Parson. Robert E. Parson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Catàlona, William J., Alan W Partin, Kevin M. Slawin, et al.. (2000). Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial. Urology. 55(3). 372–376. 35 indexed citations
2.
Ross, Philip D., et al.. (2000). Serum Bone Alkaline Phosphatase and Calcaneus Bone Density Predict Fractures: A Prospective Study. Osteoporosis International. 11(1). 76–82. 166 indexed citations
3.
Catàlona, William J., Alan W. Partin, Kevin M. Slawin, et al.. (1999). Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter Clinical Trial. The Journal of Urology. 161(1). 353–354. 59 indexed citations
4.
Southwick, Paula C., William J. Catàlona, Alan W. Partin, et al.. (1999). PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIAL. The Journal of Urology. 162(4). 1346–1351. 73 indexed citations
5.
Southwick, Paula C., William J. Catàlona, Alan W. Partin, et al.. (1999). PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIAL. The Journal of Urology. 1346–1351. 3 indexed citations
6.
Catalona, William J., Alan W. Partin, Kevin M. Slawin, et al.. (1998). Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease. JAMA. 279(19). 1542–1542. 860 indexed citations breakdown →
7.
Nixon, Randy G., Mark H. Wener, Katie Smith, et al.. (1997). Biological Variation of Prostate Specific Antigen Levels In Serum: An Evaluation of Day-to-Day Physiological Fluctuations in a Well-Defined Cohort of 24 Patients. The Journal of Urology. 157(6). 2183–2190. 68 indexed citations
8.
Southwick, Paula C., et al.. (1996). Assessment of Amyloid β Protein in Cerebrospinal Fluid as an Aid in the Diagnosis of Alzheimer's Disease. Journal of Neurochemistry. 66(1). 259–265. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Planas Breakdown of academic impact, for papers by T A Stamey Breakdown of academic impact, for papers by Takashi Imamoto Breakdown of academic impact, for papers by Naoto Kamiya Breakdown of academic impact, for papers by Jo Ann V. Antenor Breakdown of academic impact, for papers by J.S.P. Yuen Breakdown of academic impact, for papers by Daniel Keizman Breakdown of academic impact, for papers by Rosina T. Lis Breakdown of academic impact, for papers by Loredana Ciuclan
Rankless by CCL
2026